z-logo
open-access-imgOpen Access
Effect of oral administration of Lactobacillus paracasei L9 on mouse systemic immunity and the immune response in the intestine
Author(s) -
Yuanbo Zhu,
Jun Zhu,
Liang Zhao,
Ming Zhang,
Huiyuan Guo,
Fazheng Ren
Publication year - 2016
Publication title -
archives of biological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 25
eISSN - 1821-4339
pISSN - 0354-4664
DOI - 10.2298/abs150216021z
Subject(s) - lactobacillus paracasei , immune system , immunity , innate immune system , probiotic , immunology , intestinal mucosa , lactobacillus , biology , microbiology and biotechnology , in vivo , stimulation , medicine , bacteria , endocrinology , genetics
A probiotic strain Lactobacillus paracasei L9,which was isolated from human intestine, was investigated for its immunomodulatory activity in vivo. Results showed that L9 improved systemic immunity by enhancing the phagocytic activity of peritoneal macrophages, the proliferation ratio of splenocytes, the IgG level in the serum and the level of IgA in the mucosa. Further, L9induced theTh1-polarized immune response by elevating the IFN-γ/IL-4 ratio in the mucosa. This effect was confirmed by the enhanced IL-12-inducing activity of macrophages after in vitro stimulation of L9. Also detected was increased expression of TLR-2mRNA in the mucosa. We predict that L9 could enhance innate immunity by activating TLR-2 in the mucosa, and enhance acquired immunity by promoting Th1 polarization through induced production of IL-12 by macrophages

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom